Clear Street’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Clear Street’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,366	Closed	-$1.13K	–	1428
2023 Q2	$1.13K	Hold	33,366	–	–	﹤0.01%	1043
2023 Q1	$2.32K	Sell	33,366 -1,998	-6%	-$169	﹤0.01%	833
2022 Q4	$1K	Buy	35,364 +28	+0.1%	+$2	﹤0.01%	989
2022 Q3	$8K	Sell	35,336 -11,976	-25%	-$2.95K	﹤0.01%	680
2022 Q2	$5K	Buy	47,312 +14,247	+43%	+$2.36K	﹤0.01%	703
2022 Q1	$14K	Buy	+33,065	New	+$10.8K	﹤0.01%	242

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street's APGNW Position: Q3 2023 in Review

Clear Street sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 33,366 shares — an estimated $1.13K sold.

Clear Street first reported a position in APGNW in Q1 2022 and held it in 6 quarters. The position peaked at $14K in Q1 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Clear Street reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Clear Street sold 33,366 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $1.13K.
Clear Street first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2022 and held it in 6 quarters.
Clear Street's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $14K in Q1 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.